Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum
Tapia-Alveal, Olsen and Worgall develop a novel strategy for patient-specific multiple myeloma diagnostics platform using DNA aptamers. The high affinity DNA aptamers enabled detection of minimal residual disease (MRD) when conventional MRD methods assessed complete remission and are adaptable to mu...
Guardado en:
Autores principales: | Claudia Tapia-Alveal, Timothy R. Olsen, Tilla S. Worgall |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4eae892611494e1689d790423c725031 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
por: Takeshi Yoroidaka, et al.
Publicado: (2021) -
Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma.
por: Martin Trepel, et al.
Publicado: (2012) -
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
por: Benjamin G. Barwick, et al.
Publicado: (2019) -
Strategies for minimal residual disease detection: current perspectives
por: Andreani G, et al.
Publicado: (2019) -
Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing.
por: Miyoung Kim, et al.
Publicado: (2021)